NIVOLUMAB — all Canadian products
5 DINs
5 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is NIVOLUMAB, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02446626 | OPDIVO | BRISTOL-MYERS SQUIBB CANADA | Solution | Intravenous | NIVOLUMAB 10 MG | Marketed | |
| 02446634 | OPDIVO | BRISTOL-MYERS SQUIBB CANADA | Solution | Intravenous | NIVOLUMAB 10 MG | Marketed | |
| 02557320 | OPDIVO SC | BRISTOL-MYERS SQUIBB CANADA | Solution | Subcutaneous | NIVOLUMAB 120 MG | Marketed | |
| 02566931 | OPDIVO SC | BRISTOL-MYERS SQUIBB CANADA | Solution | Subcutaneous | NIVOLUMAB 120 MG | Approved | |
| 02541416 | OPDUALAG | BRISTOL-MYERS SQUIBB CANADA | Solution | Intravenous | NIVOLUMAB 240 MG; RELATLIMAB 80 MG | Marketed |
Browse other molecules: